News

Over 40,000 Americans could be affected by the shortage, according to the CDC. Adderall is the brand name for a combination drug made up of amphetamine and dextroamphetamine and used to treat ADHD.
Amid Adderall shortage, CDC says the pandemic may have ‘led to or exacerbated’ ADHD symptoms A growing body of research shows a dramatic increase in the number of younger adults seeking ...
A CDC report released Thursday estimates that prescription fills for stimulant drugs -- which are primarily used to treat ADHD -- grew by more than 11% among adults ages 25-44 during the first ...
The CDC released a statement warning of an increased risk of drug injuries and overdoses after the U.S. Department of Justice indicted two executives from the telehealth company Done on Thursday ...
As the US Adderall shortage continues, the Centers for Disease Control and Prevention released a report Thursday that noted a boom in prescriptions for the stimulant between 2020 and 2021. The CDC ...
According to the CDC, this potential disruption coincides with an ongoing prescription drug shortage involving several stimulant medications commonly prescribed to treat ADHD, including immediate ...
Done Global executives are accused of continuing to improperly prescribe Adderall and other stimulants despite social media posts claiming patients had overdosed and died.
Done Global allegedly helped prescribe more than 40 million pills of Adderall and other stimulants, and earned over $100 million in revenue, prosecutors said.
Adderall shortage continues to impact millions of Americans living with ADHD. ... the CDC recommends scheduling an appointment with prescribers as soon as possible before running low on supply.
The FDA confirmed that there is a national shortage in ADHD medication Adderall and how it might affect families. ... (CDC), young boys are much more likely to be diagnosed with ADHD than girls.
When Will the Adderall Shortage Be Over? Published Dec 07, 2022 at 5:31 PM EST Updated Dec 09, 2022 at 11:43 AM EST. By . Nick Mordowanec is a Newsweek investigative reporter based in Michigan.
The U.S. Centers for Disease Control and Prevention is warning Americans about a possible shortage in obtaining Adderall, a key treatment for attention-deficit hyperactivity disorder or ADHD.